Chelatexx Test Agent for Decreased GI Adverse Events compared to Orlistat API
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2016
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity
- Focus Proof of concept; Therapeutic Use
- 19 Sep 2016 New trial record
- 11 Aug 2016 According to M-Pharmaceuticals media release, Ronald J. Thompson MD was the principal investigator and James M. Thompson was the secondary Investigator of this study.
- 11 Aug 2016 Results published in M- pharmaceuticals media release.